VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1793073
Sex: F
Age:
State: AR

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Severe nausea; Difficulty swallowing; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included ehler-danlos syndrome type III. The patient had unspecified long list of allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified nutrients vegetarian enzymes for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 11Apr2021, the patient experienced severe nausea and difficulty swallowing. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe nausea and difficulty swallowing was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793074
Sex: M
Age:
State: SD

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: on the 18th sore arm both days; 2nd dose received around noon the 16th by midnight had a 102-103 fever lasted till around 7pm them occasionally 99-100+ fever; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) in the left arm on 16Apr2021 at 11:45 (at the age of 34-year-old) as a dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included paracetamol, chlorphenamine maleate, pseudoephedrine hydrochloride (TYLENOL SINUS) was taken occasionally for unspecified indication and unknown if ongoing. The patient previously received BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER8733) in the left arm on 26Mar2021 at 13:00 (at the age of 34-year-old) as a dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 16Apr2021 at 00:00 the patient experienced, the second dose received around noon the 16th by midnight had a 102-103 fever lasted till around 19:00 then occasionally 99-100+ fever. On the 18Apr2021 sore arm for both days. The patient did not receive any treatment for the event. The clinical outcome of the event fever and sore was recovering at this time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: TYLENOL SINUS [CHLORPHENAMINE MALEATE;PARACETAMOL;PSEUDOEPHEDRINE HYDROCHLORIDE]

Current Illness:

ID: 1793075
Sex: M
Age:
State: CO

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Diarrhea; Severe flu symptoms; Abdominal pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the right arm on 19Mar2021 at 14:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. It was reported that the patient's medical history was not relevant to COVID -19. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 20Mar2021, the patient experienced severe flu symptoms 3 days after with diarrhea, continue to have diarrhea after 6 weeks with catamount and on an unknown date in 2021, the patient also experienced abdominal pain. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe flu symptoms, diarrhea and abdominal pain was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793076
Sex: F
Age:
State: CT

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Began to sense an abnormal taste in the mouth; Smell abnormal odors; The taste and odor are like persistent bad breath.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN0150) via an unspecified route of administration in the left arm on 08Apr2021 at 15:30 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient did not receive any concomitant medications. On 10Apr2021, approximately 2 days after vaccination, the patient began to sense an abnormal taste in the mouth and smelt abnormal odours. The taste and odor were like persistent bad breath. This had persisted then ever since. The patient had been experiencing that for 5 days total as on the day of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events abnormal taste in mouth, smell abnormal odours and persistent bad breath was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793077
Sex: F
Age:
State: AL

Vax Date: 03/26/2021
Onset Date: 04/11/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: My menstrual cycle is normally like clockwork; very predictable, but it's 5 days late; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 26Mar2021 at 12:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included tubal ligation (tubes have been tied for 9 years). The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included Vitamins C&D (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and black elderberry (MANUFACTURER UNKNOWN); all medications for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 45-year-old), as a single dose for COVID-19 immunisation. On 11Apr2021, the patient experienced late period. The patient reported that her menstrual cycle was normally like clockwork; very predictable, but it was 5 days late and her tubes have been tied for 9 years. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period 5 days late was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D NOS

Current Illness:

ID: 1793078
Sex: F
Age:
State: NC

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Chills; Fever; Pain at injection site; Diarrhea; Vomiting; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 13:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic constipation, depression, anxiety, sleep apnea and COVID-19 from an unknown date. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO) and macrogol 3350 (MIRALAX), both taken for an unspecified indication; ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for birth control, all from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 16:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021, the patient experienced chills, fever, pain at injection site, diarrhea, vomiting and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL EXTRA STRENGTH). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, pain at injection site, diarrhea, vomiting and muscle pain were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO; MIRALAX; LO LOESTRIN FE

Current Illness:

ID: 1793079
Sex: F
Age:
State:

Vax Date:
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: SARS-CoV-2 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Headache; brain fog; nauseous; sleepless night; swelling injection site; pain at injection site; muscle aches; extreme tiredness (body feels like it has weights on it); This is a spontaneous report from a non-contactable healthcare professional, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) on an unknown date (at the age of 33-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) in the left arm on an unknown date (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy, pollen allergy and allergy to molds. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. On 14Apr2021 the patient experienced headache, brain fog, nauseous, sleepless night, swelling at injection site, pain at injection site, muscle aches and extreme tiredness (body feels like it has weights on it). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent SARS CoV-2 test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcomes of the events headache, brain fog, nauseous, sleepless night, swelling at injection site, pain at injection site, muscle aches and extreme tiredness (body feels like it has weights on it) was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1793080
Sex: F
Age:
State: AL

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Nausea; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 14Apr2021 at 08:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient's medical history and known allergies reported were not applicable. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 14Apr2021 at 09:30, the patient experienced nausea and diarrhoea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea and diarrhoea was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793081
Sex: F
Age:
State: PA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Severe chills; Fever; Nausea; Dizziness; Unsteady gait; Severe vertigo; This is a spontaneous report from a contactable nurse, the patient. A 77-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:00 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) and HCTZ (hydrochlorothiazide) (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 16Apr2021 at 16:00, the patient experienced severe chills, fever, nausea, dizziness which remained after 3 days also. She also experienced unsteady gait, severe vertigo and it was the worst feeling of her life. The patient was a nurse and cared for herself but could not drive and lived alone. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, fever, nausea, dizziness, unsteady gait and severe vertigo were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SYNTHROID; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1793082
Sex: F
Age:
State: MO

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:101.1; Comments: 101.1 temperature

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Chills; 101.1 temperature; Severe shoulder wrist neck aches; Severe shoulder wrist neck aches; Severe shoulder wrist neck aches; Chest pains; Shortness of breath; Anxiety; Fatigue; Jaw pain; Teeth pain; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164, Expiration date: Aug2021) via an unspecified route of administration in the left arm on 16Apr2021 at 12:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The medical history included chronic back leg pain and allergy to ACE inhibitors. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included hydrocodone bitartrate/ paracetamol (VICODIN), tramadol (MANUFACTURER UNKNOWN), alprazolam (XANAX), hydrochlorothiazide/ triamterene (MANUFACTURER UNKNOWN) and potassium (MANUFACTURER UNKNOWN); all for an unspecified indications from an unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730, Expiration date:Jul2021) via an unspecified route of administration in the left arm on 26Mar2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 19:00, the patient experienced chills ,101.1 temperature, severe shoulder wrist neck aches, chest pains, shortness of breath, anxiety, fatigue, jaw pain, teeth pain and headache. On the same date, the patient underwent body temperature test and the result was 101.1 (unspecified units). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills ,101.1 temperature, severe shoulder wrist neck aches, chest pains, shortness of breath, anxiety, fatigue, jaw pain, teeth pain and headache were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VICODIN; TRAMADOL; XANAX; TRIAMTERENE HCTZ; POTASSIUM

Current Illness:

ID: 1793083
Sex: F
Age:
State: NJ

Vax Date: 03/16/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Yesterday, 4 weeks after the seconddose- the pain has returned at the injection location (same upper right arm). It feels like I've been repeatedly punched. It hurts more today.; After second dose- Had some pretty severe pain at injection location (upper right arm) that subsided and went away after a few days.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ep7534) via an unspecified route of administration in the right arm on 16Mar2021 at 08:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6203) via an unspecified route of administration in the right arm on 23Feb2021 at 08:15 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, after second dose, the patient experienced some pretty severe pain at injection location (upper right arm) that subsided and went away after a few days. On 18Apr2021 at 15:00, 4 weeks after the second dose, the patient experienced the pain had returned at the injection location (same upper right arm). It felt like she had been repeatedly punched and it hurted more on the day of reporting. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, after second dose some pretty severe pain at injection location (upper right arm) that subsided and recovered after a few days on an unknown date in 2021, while the event pain returned at the injection location (same upper right arm) 4 weeks after the second dose, felt like she had been repeatedly punched and hurted more was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793084
Sex: M
Age:
State: NC

Vax Date: 04/10/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Night sweat; Loss of appetite; Severe body ache; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 14Apr2021 at 12:00, the patient experienced severe body ache, fever, headache, night sweat and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events severe body ache, fever, headache, night sweat and loss of appetite was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793085
Sex: F
Age:
State: NY

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: No fever but chills; Hot flashes; Severe body aches; Sore throat; Heavy lungs; Headache; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 14Apr2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 17:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient also took previously paracetamol (TYLENOL) on an unknown date and experienced drug allergy. On 15Apr2021, the patient experienced no fever but chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, hot flashes, severe body aches, sore throat, heavy lungs, headache and extreme fatigue were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793086
Sex: F
Age:
State: MN

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0171) via an unspecified route of administration in the left arm on 17Apr2021 at 08:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination included first dose of tetanus vaccine toxoid/ diphtheria vaccine toxoid/ pertussis vaccine acellular (TDAP), Lot Number: 207377 on 09Mar2021 for immunisation. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) for an unknown indication from an unknown date and unknown if ongoing. On 18Apr2021 at 00:30, the patient experienced diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was recovered on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1793087
Sex: F
Age:
State: MA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Was extremely tired and just wanted to sleep for three days!; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on 14Apr2021 at 10:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 10:45 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. On 14Apr2021 at 20:00, the patient was extremely tired and just wanted to sleep for three days. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely tired was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793088
Sex: F
Age:
State: TX

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Headache; Diarrhea; Nausea; Not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 11:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included back problems and breast cancer-remission. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 13:00, the patient experienced headache diarrhea nausea and not feeling well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, diarrhea, nausea and not feeling well was not recovered at this time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793089
Sex: M
Age:
State: WA

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Extreme abdominal cramps; Moderate testicle pain; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 17:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included insomnia from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) and zolpidem tartrate (AMBIEN) both for an unknown indication on an unknown dates and unknown if ongoing. The patient previously took cefalexin (KEFLEX) for an unknown indication on unknown date and experienced drug allergy. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 17:15 as a single dose for COVID-19 immunisation. On 18Apr2021 at 09:00, the patient experienced extreme abdominal cramps and moderate testicle pain. The events did not result in doctor or other healthcare professional office or clinic, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme abdominal cramps and moderate testicle pain were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMBIEN; TRAZODONE

Current Illness:

ID: 1793090
Sex: F
Age:
State: IL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210417; Test Name: Body temperature; Result Unstructured Data: Test Result:103; Comments: High Fever of 103 at 08:00

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: High Fever of 103; Extreme body aches and pains; Chills (was extremely cold); Cough; Unable to take a deep breath; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, gastric bypass and vsg surgery (sleeve gastrectomy). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B-12), curcuma longa rhizome (TURMERIC) and vitamin d nos (MANUFACTURER UNKNOWN) and multi-vitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 26Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 08:00, the patient experienced high fever of 103(unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever of 103 (unspecified units), extreme body aches and pains, chills (was extremely cold), cough and unable to take a deep breath was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IRON; VITAMIN B-12; TURMERIC [CURCUMA LONGA RHIZOME]; VITAMIN D NOS

Current Illness:

ID: 1793091
Sex: F
Age:
State: CT

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Headache (4/18).; In summary, bed all day 4/17 & 4/18 feeling tremendously ill, completely unable to do anything; In summary, bed all day 4/17 & 4/18 feeling tremendously ill, completely unable to do anything; Fatigue (4/17 & 4/18); Sporadic sharp pain behind right rib (4/17 & 4/18); Lack of appetite (4/17 & 4/18); Diarrhea - evening of 4/15 and during day 4/17; Chills (4/17 & 4/18) - severe, could not warm up despite layers of clothing, comforters, and heat pad. then would be extremely hot. Back and forth; Nausea (4/17 and 4/18)- severe; Stomach cramps (severe 4/17 and 4/18, mild 4/19) - sporadic stomach cramps on dates specified. Diminished significantly but ongoing, increaseswith movement; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 15Apr2021 at 09:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and interstitial cystitis and irritable bowel syndrome (IBS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sumatriptan (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); for unknown indication from an unknown date and unknown if ongoing. On 15Apr2021, evening the patient experienced diarrhea and during day of 17Apr2021. On 15Apr2021, the patient experienced chills (on 17Apr2021 and 18Apr2021)- severe, could not warm up despite layers of clothing, comforters, and heat pad. Then would be extremely hot, back and forth. On 15Apr2021, the patient experienced nausea and on 17Apr2021 and 18Apr2021 it was severe. The patient had severe stomach cramps on 17Apr2021 and 18Apr2021. On 19Apr2021, the patient had mild stomach cramps. The patient had sporadic stomach cramps on dates specified, diminished significantly but ongoing and increased with movement. On 17 Apr2021 and 18Apr2021, the patient experienced fatigue, developed sporadic sharp pain behind right rib and lack of appetite. On 18pr2021, the patient experienced headache. In summary, in bed all day on 17Apr2021 and 18Apr2021, feeling tremendously ill, completely unable to do anything. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, chills severe, could not warm up despite layers of clothing, comforters, and heat pad. Then would be extremely hot, back and forth, nausea, severe stomach cramps, mild stomach cramps, sporadic stomach cramps on dates specified, diminished significantly but ongoing and increased with movement, fatigue, developed sporadic sharp pain behind right rib, lack of appetite, headache in bed all day, feeling tremendously ill, completely unable to do anything was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SUMATRIPTAN; IBUPROFEN

Current Illness:

ID: 1793092
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Chills; Nausea; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included linaclotide (LINZESS) and blood pressure medications (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 14:00, the patient experienced chills, nausea, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, nausea, headache and diarrhea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LINZESS

Current Illness:

ID: 1793093
Sex: F
Age:
State: FL

Vax Date: 04/12/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: she has injection site pain; she has injection site pain and swelling; little lump in axillary nodes region; she had irritated throat; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional. A 49-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 12Apr2021 as dose 1, single for covid-19 immunization. Medical history included asthma, she suffers asthma from an unknown date to ongoing. The patient's concomitant medications were not reported. On an unspecified date in 2021 the patient experienced she has injection site pain and swelling, little lump in axillary nodes region, she had irritated throat. Patient reported that she has not seen a physician and she was scheduled for a mammography test and she was afraid that the swollen lymph node could affect the results. The patient wanted to know how long the adverse effects will last after first dose administration of Pfizer's COVID-19 vaccine, requested information about whether Advil was an adequate medication for symptoms management caused by first dose administration of Pfizer's COVID-19 vaccine and requested information about whether the second dose of Pfizer's COVID-19 vaccine would be worse as to adverse effects. Treatment received with Advil for injection site pain and swelling, symptoms management. Outcome of the events were unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness: Asthma (she suffers Asthma).

ID: 1793094
Sex: F
Age:
State: KY

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210419; Test Name: Body temperature; Result Unstructured Data: Test Result:101 degree; Comments: Fever; Test Date: 20210407; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Unevaluable event

Symptoms: Body aches; Body chills; Nausea; 101 degree fever; Headache; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 18Apr2021 at 13:45 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, endometriosis, and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ethinylestradiol, norgestimate (SPRINTEC) and fexofenadine hydrochloride (ALLEGRA); all for unknown indication from unknown date, and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 19Apr2021 at 05:00, the patient experienced body aches, body chills, nausea, 101 degree fever, headache, and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 19Apr2021, the patient underwent body temperature test and the result was 101 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, body chills, nausea, 101 degree fever, headache, and dizziness were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; SPRINTEC; ALLEGRA

Current Illness:

ID: 1793095
Sex: F
Age:
State: PA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Onset of feeling tired; Irritable; Headache; Fever (not documented with a thermometer); Achy arm; This is a spontaneous report from a contactable physician. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Apr2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included iodine contrast allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient received any medication within two weeks of vaccination. On 16Apr2021, starting 3 hours after the second dose of the Pfizer COVID vaccine, the patient experienced the onset of feeling tired, irritable, headache, fever (not documented with a thermometer) and achy arm. All the events resolved within about 3 to 4 hours except for local arm ache which the patient felt was not unusual for a vaccine. The patient was the reporter's friend and she had called on 18Apr2021 and related the above, "so that you can report it". The reporting physician was not the patient's physician. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feeling tired, irritable, headache, fever and achy arm were resolved on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793096
Sex: F
Age:
State: TN

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: X- ray; Result Unstructured Data: Test Result:RESULT UNKNOWN

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: I developed Numbness in right leg and heaviness; I developed Numbness in right leg and heaviness; I now have extreme squeaky and pain when walking; I now have extreme squeaky and pain when walking. I have not been able to daily activities and have had to get a cane to help me walk.; I have not been able to daily activities and have had to get a cane to help me walk.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 15Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome, fibromyalgia and hip replacement two years ago. Concomitant medications taken within two weeks of vaccination included duloxetine hydrochloride (CYMBALTA), gabapentin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received tetanus vaccine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 19:30, the patient developed numbness in right leg and heaviness. The patient had a hip replacement two years ago and no problems up till time of vaccine. The patient, on 15Apr2021 at 19:30, had extreme squeaky and pain when walking. She had not been able to do daily activities and had to get a cane to help her walk. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included medicine (unspecified). On an unknown date in Apr2021, the patient had an x-ray taken and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events developed numbness in right leg and heaviness; had extreme squeaky and pain when walking; had not been able to do daily activities and has had to get a cane to help her walk was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: CYMBALTA; GABAPENTIN; LISINOPRIL

Current Illness:

ID: 1793097
Sex: M
Age:
State: MD

Vax Date: 04/14/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Around 6:00 am on April 18th, 2021, "my" body developed hives, on "my" arms, legs.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included may be allergy to penicillin and cephalosporin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination included first dose of influenza vaccine, Lot number: unknown via an unspecified route of administration in the left arm on 09Mar2021 as a single dose for immunization. Concomitant medications included multivitamins (VITAPRIME) by labs for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 14:45 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 06:00, 88 hours after receiving the second shot of vaccination, the patient body developed hives, on his arms and legs. On 19Apr2021, as writing this, he did not see hives anymore. The event did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were taken as a result of the reported event and included treatment with fexofenadine hydrochloride (ALLEGRA) from an unspecified date in Apr2021 and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body developed hives, on arms and legs was resolved on 19Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793098
Sex: U
Age:
State: CT

Vax Date: 04/13/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Intermittent numbness and tingling in lips; Intermittent numbness and tingling in lips; Red itchy rash under left eye.; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 11:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS) and known allergy to crab. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included norethisterone (NORLYDA) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient experienced intermittent numbness and tingling in lips and red itchy rash under left eye. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intermittent numbness and tingling in lips and red itchy rash under left eye were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: NORLYDA

Current Illness:

ID: 1793099
Sex: M
Age:
State: MN

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fatigue (1 week); Headaches (1 week); Diarrhea (2 days); Joint pain (2 weeks); This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CR8733) via an unspecified route of administration in the right arm on 29Mar2021 at 12:45 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included bicuspid aortic valve, fatty liver, paroxysmal supraventricular tachycardia (paroxysmal SVT), anomalous right coronary artery and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 29Mar2021, the patient experienced fatigue (1 week), headaches (1 week), diarrhea (2 days) and joint pain (2 weeks). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event diarrhea (2 days) was recovered on 31Mar2021, after the duration of 2 days. The clinical outcome of the events fatigue (1 week) and headaches (1 week) was recovered on an unspecified date in Apr2021, after the duration of 1 week. The clinical outcome of the event joint pain (2 weeks) was recovered on an unspecified date in Apr2021, after the duration of 2 weeks. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL; FEXOFENADINE HYDROCHLORIDE

Current Illness:

ID: 1793100
Sex: F
Age:
State: VA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe joint pain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the arm left on 17Apr2021 at 15:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 15:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 00:00, the patient experienced severe joint pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of severe joint pain and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and liquids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe joint pain was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793101
Sex: F
Age:
State: NY

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Looser stools; Feel pretty lousy; Very fatigued; Headachy; Lack of mental clarity; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO158) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included sensitive as it was reported that the patient was not aware of any known allergies but was sensitive. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included natural progesterone (MANUFACTURER UNKNOWN), ergocalciferol (Vit d), ascorbic acid (Vit c) and other unspecified medications; all for unknown indications from unknown dates and unknown if ongoing. On 10Apr2021 at 17:00, the patient felt pretty lousy, very fatigued, headachy and lack of mental clarity. On 19Apr2021, just at the time of this report, the patient had looser stools. The events felt pretty lousy, very fatigued, headachy and lack of mental clarity were resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feel pretty lousy, very fatigued, headachy, lack of mental clarity and looser stools was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROGESTERONE; VIT D [ERGOCALCIFEROL]; VIT C

Current Illness:

ID: 1793102
Sex: F
Age:
State: MN

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: massive headache with migraine; diarrhea; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; 36 hours after 2nd vaccine dose, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing; nauseous; dizzy; headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 14Apr2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic asthma from cat dander and allergy to sulfa antibiotics. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration on 24Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation and received metoclopramide (REGLAN), hydrocodone bitartrate/paracetamol (NORCO) and trazodone (MANUFACTURER UNKNOWN); all on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 11:25, within 10 minutes, the patient experienced nauseous, dizzy and headache and had same impact for 24 hours. On 15Apr2021 at 23:15, 36 hours after 2nd vaccine dose, the patient experienced respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing. On 18Apr2021, 4 days later, the patient experienced massive headache with migraine all day (24 hour long) and diarrhea for four hours. On 19Apr2021, the patient felt fine again. The patient did not receive any treatment for the nauseous, dizzy, headache, massive headache with migraine and diarrhea, Therapeutic measures were taken as a result of respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing and included treatment herself with emergency inhaler (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nauseous, dizzy, headache, respiratory asthma like event with heaviness/pain in chest and lung/productive cough with wheezing and massive headache with migraine was recovered on unknown date in Apr2021 and of the event diarrhea was recovered on 18Apr2021, after the duration of 4 hours. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793103
Sex: F
Age:
State: LA

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: Blood pressure; Result Unstructured Data: Test Result:Increased blood pressure; Test Date: 20210416; Test Name: Heart rate; Result Unstructured Data: Test Result:Rapid heart rate

Allergies:

Symptom List: Injection site pain

Symptoms: 1 week post vaccination felt chills; 1 week post vaccination felt brain fog; Headache above eyes; Body aches; Rapid heart rate; Blood pressure increased; Tiredness; Fatigue; Day post vaccination a sore and throbing LT arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, vertigo, Central Nervous System hypersensitivity, inner ear vestibulopathy, anxiety, osteopenia and hypercholesteremia. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin calcium (LIPITOR), calcium carbonate (CALTRATE), vitamin d not otherwise specified (VITAMIN D), alendronate sodium (FOSAMAX), ascorbic acid (VITAMIN C) and beclometasone dipropionate (QVAR); all taken for unknown indication from an unknown dates and unknown if ongoing. On 10Apr2021, a day post vaccination, the patient experienced sore and throbbing left arm. On 16Apr2021 at 22:30, 1 week post vaccination, the patient felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings, tiredness and fatigue. These symptoms were lasting for 3 days and on 19apr2021 the patient felt somewhat improved although was feeling fatigued. On 16Apr2021 at 22:30, the patient underwent lab tests and procedures which included heart rate and blood pressure and the result was found to be rapid for heart rate and increased for blood pressure. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore, throbbing left arm, felt chills, brain fog, headache above eyes, body aches, rapid heart rate, increased blood pressure readings and tiredness were recovering, while the event fatigue was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LIPITOR; CALTRATE [CALCIUM CARBONATE]; VITAMIN D NOS; FOSAMAX; VITAMIN C [ASCORBIC ACID]; QVAR

Current Illness:

ID: 1793105
Sex: F
Age:
State: CO

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: chills; fatigue; joint pain; headaches; This is a spontaneous report from a contactable consumer or other non-health care professional received from Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1, single via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced chills, fatigue, joint pain (arthralgia) and headaches on an unspecified date. The caller called on behalf of her mother asking if she could take any medications for her symptoms or that would affect the vaccine. At the time of reporting, the outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1793107
Sex: F
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/11/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Hives all over body; whole body allergic reaction; rash, rash was worse and that it was on her "face, arms, legs, back, everywhere.; This is a spontaneous report from a contactable consumer (patient). A 48-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8733, Expiration date: Unknown), via an unspecified route of administration, administered in arm left on 05Apr2021 at 05:30 PM (age at vaccination was 48 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. No other vaccines were received within four weeks prior to the administration of bnt162b2. No family medical history reported. Medical history included asthma from 2008 and was ongoing, reactions to food (there wasn't anything specific, but that she has broken out in hives due to food before) from an unspecified date and was ongoing, anxiety and depression from an unknown date and unknown if ongoing, hives to cephalosporins from 2004 and was ongoing, irregular heart rate from 2018 and was ongoing, insomnia from 2018 and was ongoing, allergies (she has had allergies since she was a child) from an unspecified date and was ongoing, Covid (Had Covid in December and don't want to get it again) from dec2020 and unknown if ongoing. Concomitant medications included montelukast sodium (SINGULAIR) taken for allergies and asthma, from an unspecified date and was ongoing; metoprolol taken to regulate heart rate, from 2016 and was ongoing; levocetirizine dihydrochloride (XYZAL) taken for allergies, from an unspecified date and was ongoing; trazodone taken for an unspecified indication, from 2016 and was ongoing; chlorphenamine hydrochloride taken for allergies, from an unspecified date and was ongoing. Historical vaccine included Flu shot and Pneumovax 23 on an unspecified date in Feb2021 for an unspecified indication. Report stated that the patient got the first dose of the Covid-19 vaccine on 05Apr2021 in her left arm. She also reported that the hive had started on her left arm in 11Apr2021. The hives did not start at the injection site, but did start on her left arm and then started going everywhere. On the evening of 11Apr2021, hives started all over her body. The hives were all over her face from head to toe. The patient stated that the rash was worse and that it was on her "face, arms, legs, back, everywhere. The patient stated that she ended up with a whole body allergic reaction, rash but not an anaphylactic reaction. She also stated that her physician did not know what to do for her hives and allergic reaction. The patient went through one round of 3 days of steroids, over the counter, the hives had continued to spread. The reporter stated that since days had gone by since 11Apr2021, On 20Apr2021, was probably the worst day. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment for the events included: patient took a 3 day course of steroids and had been using hydroxyzine 25 mg, a topical cream that was not really doing a whole lot; Xyzal 5 mg and Chlorphenamine 4 mg (over the counter); Clobetasol Propionate 0.05%, topical cream that was not really doing a whole lot; Hydroxyzine 25 mg made her completely go to sleep, and she could only take the hydroxyzine at night; prednisone 20 mg tablets once daily for 3 days. No investigation assessment was reported. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Outcome of the events hives was not recovered and other events was unknown. Follow-up (09Jul2021): Follow-up attempts completed. No further information expected.

Other Meds: SINGULAIR; METOPROLOL; XYZAL; TRAZODONE; CHLORPHENAMINE HYDROCHLORIDE

Current Illness: Allergy (had allergies since she was a child); Asthma; Food allergy (there wasn't anything specific, but that she has broken out in hives due to food before); Heart rate irregular; Insomnia

ID: 1793108
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Short of breath; Sneezing; Sneezing /a lot of mucus; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot number was not reported), dose number unknown via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medication was not reported. After 11 days of receiving the Pfizer vaccine on an unspecified date the patient experienced short of breath, sneezing continuously, and a lot of mucus only when patient only consumed ice cream, and this was repeated more than once, and it did not happen before. The clinical outcome of the events was reported as unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1793109
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Delayed menstrual; More than usual cramping; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on an unknown date (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported was not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On an unknown date, the patient experienced delayed menstrual, more than usual cramping with nausea. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not tested for COVID-19. The clinical outcome of the events delayed menstrual, more than usual cramping with nausea was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793110
Sex: F
Age:
State: FL

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Delayed period; Lots of abdominal cramping; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021(at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 10Apr2021, the patient experienced delayed period and lots of abdominal cramping. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events delayed period and lots of abdominal cramping was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793111
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Fever; muscle aches; nausea; chills; chest tightness (hard to take deep breathe); fatigue; head ache; This is a spontaneous report from a non-contactable consumer (husband). A 41-years-old non pregnant female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 10:00 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 41 years). Medical history included, food allergy (shellfish) from an unknown date and unknown if ongoing. Concomitant medications included essential oils nos, Nuva ring (ETHINYLESTRADIOL, ETONOGESTREL), multi-vitamins, probiotics taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 23Mar2021 09:30 AM as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior vaccine and post vaccine the patient was not diagnosed with COVID-19. The patient experienced fever, muscle aches, chills, chest tightness (hard to take deep breathe), fatigue, headache on 14Apr2021. No treatment was received for the adverse events. The clinical outcome of the events were recovering. No follow-up attempts possible. No further information expected. bnt162b2 batch cannot be obtained.

Other Meds: ESSENTIAL OILS NOS; PROBIOTICS; NUVARING

Current Illness:

ID: 1793112
Sex: F
Age:
State: KS

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Severe chills; Fever; Vomiting; Diarrhea; Fatigue; Headache; Increased tinnitus; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 12Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and allergy to sulpha drugs. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (MANUFACTURER UNKNOWN) and hydrochlorothiazide, olmesartan medoxomil (BENICAR HCT), both taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 22Mar2021 at 16:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 23:00, the patient experienced severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ROSUVASTATIN CALCIUM; BENICAR HCT

Current Illness:

ID: 1793113
Sex: F
Age:
State: MA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Cold sensation over entire body; Body Aches; sever headache; swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit; fatigue; redish bruising; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 18Apr2021 16:45 (Age at Vaccination 28-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included Allergies to medications, food, or other products:percoset, vicodin, alieve, codine, zythromax, osmopret, bactrim, ceftriaxone, bee stings. Concomitant medications included spironolactone; doxycycline; norethindrone taken for an unspecified indication, start and stop date were not reported. The patient experienced cold sensation over entire body, body aches , sever headache, swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit , fatigue, redish bruising on 18Apr2021 16:45. No treatment were provided for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Apr2021 hcp became aware of the events. The patient was not tested covid prior or post vaccination. The clinical outcome of the events was unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.

Other Meds: SPIRONOLACTONE; DOXYCYCLINE; NORETHINDRONE [NORETHISTERONE]

Current Illness:

ID: 1793114
Sex: M
Age:
State: NM

Vax Date: 03/25/2021
Onset Date: 04/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID-19; Test Result: Positive ; Test Date: 20210421; Test Name: COVID-19; Test Result: Negative ; Comments: Cheek/Mouth Swab

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: I broke out in a rash on most parts of my body; arms, legs, back, and buttocks/ Bad rash all over my body; will not go; The rash itches very bad, I scratch at it and it gets worse and seems to spread to more parts of my body; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 60-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6204), via an unknown route of administration in right arm on 25Mar2021 at 09:00 (at the age of 60-years-old) as dose 2, single for COVID-19 immunization at pharmacy. The patient's medical history included COVID-19 from an unknown date. No allergies to medications, food, or other products. Other medical history was none. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No, any other medications he received within 2 weeks of vaccination. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6206) in left arm on 04Mar2021 at 08:45 (at the age of 60-years-old) as historical vaccine as dose 1, single for COVID-19 immunization. On 01Apr2021 at 14:30, the patient broke out in a rash on most parts of his body; arms, legs, back, and buttocks. Rash would not go away, his doctor prescribed some ointment, but it has not helped much, the rash itches very bad, he scratch at it and it gets worse and seems to spread to more parts of his body. On 05Apr2021 at 18:00, bad rash all over his body; will not go away. The adverse event result to visit doctor or other healthcare professional office or clinic. On 21Apr2021, the patient had COVID test post vaccination by mouth swab, resulted in negative. Triamcinolone and steroid shot were received as treatment for the adverse event. The outcome of events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793115
Sex: M
Age:
State: VA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Allergic reaction, started with mouth and nose going numb for 1st injection; Allergic reaction, started with mouth and nose going numb for 1st injection; Allergic reaction, started with mouth and nose going numb for 1st injection; This is a spontaneous report received from a contactable consumer (patient) reported for himself. A 41-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: FR8730), via an unknown route of administration in left arm on 24Mar2021 at 10:00 (at the age of 41-years-old) as dose 1, single for COVID-19 immunization at hospital. The patient's medical history included asthma and had no allergies to medications, food, or other products. Concomitant medication included tizanidine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced allergic reaction, started with mouth and nose going numb for 1st injection. Before the 1st injection he had never had an allergic reaction. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. No treatment received for the adverse event. The outcome of events was recovered on an unknown date in 2021. Follow-up attempts completed. No further information expected.

Other Meds: TIZANIDINE

Current Illness:

ID: 1793116
Sex: F
Age:
State: VA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Felling of being unwell; Feverish; Diarrhea; Began with a slight headache, then Nausea the first evening. The second day started with Nausea, feverish, diarrhea. Continued with a general feeling of being unwell on the 3rd day (nausea, diarrhea,; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm right on 14Apr2021 at 17:30(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Apr2021 at 20:00, the patient reported that it began with a slight headache, then nausea the first evening and the second day started with nausea, feverish, diarrhea, continued with a general feeling of being unwell on the 3rd day (nausea, diarrhea, but no headache). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began with a slight headache and feverish was recovered on unknown date in Mar2021. The clinical outcome of the events, nausea, diarrhea and feeling of being unwell was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1793117
Sex: F
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Severe kidney pain; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), LEXUS PRO and ethinylestradiol/etonogestrel (NUVARING); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021, the patient experienced severe kidney pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe kidney pain was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE; WELLBUTRIN; NUVARING

Current Illness:

ID: 1793118
Sex: M
Age:
State: OH

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Chills; Fever; Body pain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0164) via an unspecified route of administration in the right arm on 17Apr2021 at 17:30 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks of COVID-19 vaccine. The patient did not received any other medications in two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8733) via an unspecified route of administration in the right arm on 29Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 03:00, the patient experienced chills, fever, body pain and fatigue. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, body pain and fatigue were not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1793119
Sex: M
Age:
State: GA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Trouble breathing; Throat was a little swollen; Sinuses were stuffy; Got tired and went to bed; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERB737) via an unspecified route of administration in the left arm on 13Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, diabetes 2 (type 2 diabetes mellitus) and knee arthritis. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide / losartan potassium (LOSARTAN/HCTZ), diltiazem (MANUFACTURER UNKNOWN), and glibenclamide (GLYBURIDE); all for an unknown indication from an unknown date and unknown if ongoing. On 13Apr2021, at approximately 21:00, the patient got tired and went to bed. On 14Apr2021, at 00:00 the patient woke up at mid-night and experienced trouble breathing and also felt like throat was a little swollen, but had no problem in swallowing, sinuses were stuffy but had no allergies and no sinus problems before. The patient sat up the rest of the night and the breathing got better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events got tired, trouble breathing, throat was a little swollen, and sinuses were stuffy was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: METOPROLOL; LOSARTAN/HCTZ; DILTIAZEM; GLYBURIDE

Current Illness:

ID: 1793120
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: allergic reaction; rash between buttocks and legs; This is a spontaneous report from a non-contactable consumer reported for a patient. A female patient of an unknown age received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown), via an unknown route of ministration on an unknown date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unknown date, the patient experienced allergic reaction some days after vaccination, she had a rash between buttocks and legs. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1793121
Sex: F
Age:
State:

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210416; Test Name: Body temperature; Result Unstructured Data: Test Result:100 degrees; Comments: Fever

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: 100 degrees fever; Nausea; Chills; Diarrhea; Unusually strong headache; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 at 15:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 16Apr2021, at 09:00, the patient experienced 100 degrees fever, nausea, chills, diarrhea and unusually strong headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events 100 degrees fever, nausea, chills, diarrhea and unusually strong headache was recovering at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1793122
Sex: F
Age:
State: MN

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: Body temperature; Result Unstructured Data: Test Result:101.3

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Fever of 101.3, joint pain throughout body, pain in kidney area, severe headache; Joint pain throughout body; Pain in kidney area; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 14Apr2021 at 11:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 17Mar2021 at 11:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 03:00, the patient experienced fever of 101.3, joint pain throughout body, pain in kidney area and severe headache and on the same day, the patient underwent body temperature test and the result was 101.3 (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, fever of 101.3, joint pain throughout body, pain in kidney area and severe headache was recovered on unknown date on Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; VITAMIN D NOS

Current Illness:

ID: 1793123
Sex: F
Age:
State: IL

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe headache; Chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 15Apr2021 at 05:00, the patient experienced severe headache, chills and muscle aches. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with extra-strength acetaminophen (TYNELOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, chills and muscle aches was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1793124
Sex: F
Age:
State: IL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Swelling of R lymph nodes; Swelling of R lymph nodes resulting in severe pain; This is a spontaneous report from a contactable healthcare professional. A 29-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the arm right on 13Jan2021 at 17:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome, depression, patellar instability, milk soy allergy, adhesive allergy, allergy to dogs and cats, beeswax allergy. The patient previously received cefalexin(CEPHALEXIN) and cortisone injection(MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC) and birth control pill (MANUFACTURER UNKNOWN); all from unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm left at 16:45 (at the age of 29-years-old) on 23Dec2020 as a single dose for COVID-19 immunisation. On 13Jan2021 at 22:15 the patient experienced swelling of R lymph nodes resulting in severe pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of R lymph nodes resulting in severe pain was recovered in 3 weeks post-vaccine on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am